1 North Wealth Services’s AbbVie ABBV Stock Holding History

1 North Wealth Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.28K	Hold	21	–	–	﹤0.01%	226
2026 Q1	$4.57K	Buy	+21	New	+$4.66K	﹤0.01%	204
2019 Q4	$27K	Buy	302 +132	+78%	+$11K	0.02%	123
2019 Q3	$13K	Buy	+170	New	+$11.7K	0.01%	138
2019 Q1	$14K	Hold	170	–	–	0.01%	129
2018 Q4	$16K	Buy	+170	New	+$14.9K	0.01%	115

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

1 North Wealth Services's ABBV Position: Q2 2026 in Review

1 North Wealth Services held its AbbVie (ABBV) position steady in Q2 2026 at 21 shares worth $5.28K. The position accounts for ﹤0.01% of the portfolio, ranked #226.

1 North Wealth Services first reported a position in ABBV in Q4 2018 and has held it in 6 quarters since. The position peaked at $27K in Q4 2019. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

1 North Wealth Services held 21 shares of AbbVie worth $5.28K as of Q2 2026.
1 North Wealth Services left its AbbVie share count unchanged in Q2 2026.
AbbVie made up ﹤0.01% of 1 North Wealth Services's portfolio in Q2 2026, its #226 holding.
1 North Wealth Services first reported a position in AbbVie in Q4 2018 and has held it in 6 quarters since.
1 North Wealth Services's AbbVie position peaked at $27K in Q4 2019.
4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on 1 North Wealth Services's 13F filing for Q2 2026, filed 3 Aug 2026.